Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective – A systematic review of recently published literature on real-world data
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective – A systematic review of recently published literature on real-world data
Authors
Keywords
Real-world evidence, Randomised controlled trial, Enhanced influenza vaccine, Adjuvanted influenza vaccine, Older adults, Vaccination recommendation
Journal
VACCINE
Volume 40, Issue 22, Pages 2999-3008
Publisher
Elsevier BV
Online
2022-04-19
DOI
10.1016/j.vaccine.2022.04.019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis
- (2021) Jason K.H. Lee et al. VACCINE
- Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults
- (2021) Kenneth E. Schmader et al. JAMA Network Open
- Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-Derived Quadrivalent Inactivated Influenza Vaccines and High-Dose Trivalent Influenza Vaccine in Preventing Influenza-Related Medical Encounters in US Adults ≥65 Years During the 2017-2018 and 2018-2019 Influenza Seasons
- (2021) Constantina Boikos et al. CLINICAL INFECTIOUS DISEASES
- A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018–19 influenza season
- (2021) Stephen I. Pelton et al. VACCINE
- Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis
- (2021) Brenda L. Coleman et al. Influenza and Other Respiratory Viruses
- Relative effectiveness of influenza vaccines in elderly persons in the United States, 2012/2013-2017/2018 seasons
- (2021) Marina Amaral de Avila Machado et al. npj Vaccines
- Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications
- (2021) Constantina Boikos et al. Vaccines
- Influenza Vaccines: Successes and Continuing Challenges
- (2021) Tanja Becker et al. JOURNAL OF INFECTIOUS DISEASES
- mRNA flu shots move into trials
- (2021) Elie Dolgin NATURE REVIEWS DRUG DISCOVERY
- Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis
- (2021) Myron J. Levin et al. Vaccines
- Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19
- (2020) Hector S Izurieta et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of influenza vaccine in reducing influenza-associated hospitalizations and deaths among the elderly population; Lazio region, Italy, season 2016-2017
- (2020) Massimo Fabiani et al. Expert Review of Vaccines
- Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults
- (2020) Caitlin Lees et al. JOURNAL OF INFECTIOUS DISEASES
- Preventing the Risk of Hospitalization for Respiratory Complications of Influenza among the Elderly: Is There a Better Influenza Vaccination Strategy? A Retrospective Population Study
- (2020) Silvia Cocchio et al. Vaccines
- Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season
- (2020) Stephen I. Pelton et al. Vaccines
- Aging and influenza vaccine-induced immunity
- (2019) Haley L. Dugan et al. CELLULAR IMMUNOLOGY
- Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017–18
- (2018) Hector S Izurieta et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial
- (2013) Hans C Rümke et al. BMC INFECTIOUS DISEASES
- Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
- (2012) S. Mannino et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The history of MF59®adjuvant: a phoenix that arose from the ashes
- (2012) Derek T O’Hagan et al. Expert Review of Vaccines
- The mechanism of action of MF59 – An innately attractive adjuvant formulation
- (2012) D.T. O’Hagan et al. VACCINE
- MF59 adjuvant: the best insurance against influenza strain diversity
- (2011) Derek T O’Hagan et al. Expert Review of Vaccines
- Influenza vaccine responses in older adults
- (2010) Janet E. McElhaney AGEING RESEARCH REVIEWS
- Fading Immune Protection in Old Age: Vaccination in the Elderly
- (2009) B. Grubeck-Loebenstein JOURNAL OF COMPARATIVE PATHOLOGY
- Influenza control in the 21st century: Optimizing protection of older adults
- (2009) Arnold S. Monto et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now